Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by 4Justiceon Aug 13, 2021 10:07am
57 Views
Post# 33700164

RE:RE:RE:RE:RE:RE:RE:RE:TOMMY THE DUMMY

RE:RE:RE:RE:RE:RE:RE:RE:TOMMY THE DUMMYALDO

GoBBs said exactly what I think...in better English

take time to read carefully Q2 MD&A. If they want to hide something they will disclose today after the close. If they thought they have a rely good business plan with the miney they have they will disclose Monday before the opening. We gona chalenge our conclusion from an official and same document.

Good luck
<< Previous
Bullboard Posts
Next >>